Subscribe to our Newsletters !!
How are viruses different from bacteria apex ? O
Pharmaceutical laboratories have been adopting imm
Generally, a debate about Isopure protein and regu
Alembic Pharmaceuticals Limited appoints Mr. Manis
The importance of comparing the treatment of asthm
It is important to understand that natural remedie
In a world constantly in motion, Microbioz India r
New literature from Copley Scientific, the world’s leading manufacturer and supplier of inhaled product testing equipment, highlights the importance of controlling temperature, relative humidity (RH) and electrostatics in the test environment to maximise the integrity and value of inhaler test data. In an application note and white paper, company experts provide insight into the issues and practical guidance for improvement including experimental data demonstrating the performance of EnviroMate™, a benchtop environmental control chamber for inhaler testing. An interesting and informative read for anyone looking to minimise variability in inhaler testing, the new literature is freely available for download.
“Variability in the test environment is a frequently overlooked contributor to poor quality data and out-of-specification results,” said Clair Brooks, Applications Specialist, Copley. “This white paper explains the links between test environment, orally inhaled product (OIP) performance and measured metrics, while the app note provides experimental evidence showing how EnviroMate can help. Both make good reading for those with a problem with temperature, RH or electrostatics control within the lab.”
‘Establishing a robust environment for inhaler testing’, the recently released white paper, addresses questions such as:
‘Reducing variability in the inhaler testing environment’ is a complementary application note detailing an experimental study of the performance of an EnviroMate. The resulting data show how the unit delivers constant temperature and RH in the face of variability in an air-conditioned lab typical of those used for inhaler testing.
“During training, customers routinely ask how to tackle sources of variability and improve data integrity, so we’re delighted to add these valuable pieces to our literature library,” concludes Brooks.
Read the white paper here, the app note here, or find out more about the EnviroMate here.
New literature from Copley explains the multiple impacts of temperature, RH and electrostatics on inhaler test data and discusses strategies for mitigation.
Copley Scientific is widely recognised as the world’s leading manufacturer and supplier of inhaled product testing equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing.
Copley’s pharmaceutical product range includes testing equipment for all types of orally inhaled and nasal drug products – metered-dose inhalers, dry powder inhalers, nebulisers and nasal products – with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories, semisolids and transdermals.
Used from R&D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley works in partnership with specialist distributors, extending localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley products. www.copleyscientific.com
Press information/Company contact: Rosanna Kelly, Marketing Manager, Copley Scientific Limited Colwick Quays Business Park, Road No. 2, Nottingham, NG4 2JY, UK Tel: +44 (0)115 961 6229 Fax: +44 (0)115 961 7637 mediarelations@copleyscientific.co.uk www.copleyscientific.com
